Comments from Speaker
An IP High Court (IPHC) decision in 2019, which provides insight on how to protect a newly discovered mechanism in the field of life science in Japan, will be presented. The IPHC decision provides a specific example of how inherency is handled. The IPHC also provides a specific example of discussing (by the IPHC) a new patient group in order to establish novelty for this specific case. We hope that this webinar will be particularly useful to those who are handling life science cases.
- The webinar is expected to consist of a 20 to 30-minute presentation and a 5 to 10-minute Q&A session.
- If you miss watching the live session, you will receive an on-demand recorded video link a day after the live session is over. Please still register with the above link.
- This webinar is aimed at providing IP information to our business partners and clients from overseas. Registration from persons who work for IP firms or law firms in Japan will not be approved as this may be deemed as a conflict of interest with our business.